New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
13:25 EDTCTRX, CTRX, CTRX, CVS, CVS, CVS, ESRX, ESRX, ESRXLeerink's healthcare services analyst holds an analyst/industry conference call
Healthcare Technology and Distribution Analyst Larsen discusses the perceived differences between Medco and Express Scripts from the perspective of Managed Care on an Analyst/Industry conference call to be held on January 28 at 2 pm.
News For CTRX;CVS;ESRX From The Last 14 Days
Check below for free stories on CTRX;CVS;ESRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 1, 2014
14:53 EDTCTRXCatamaran reported strong results, says Maxim
Subscribe for More Information
06:11 EDTCTRXCatamaran sees FY14 adjusted EPS $2.12-$2.22, consensus $2.19
Subscribe for More Information
06:09 EDTCTRXCatamaran reports Q2 adjusted EPS 54c, consensus 51c
Subscribe for More Information
July 31, 2014
15:38 EDTCTRXNotable companies reporting before tomorrow's open
Subscribe for More Information
14:59 EDTESRXInsys sinks after analyst sees drug to be excluded from coverage
Subscribe for More Information
08:25 EDTCVSCVS Caremark earns first Community Pharmacy accreditation from URAC
Subscribe for More Information
July 30, 2014
09:04 EDTESRXOn The Fly: Pre-market Movers
Subscribe for More Information
09:00 EDTCVSMcKesson extends pharmaceutical distribution agreement with CVS Caremark
McKesson Corporation (MCK) announced a three-year extension of its existing distribution agreement with CVS Caremark (CVS) through June, 2019. “We have a long track record of delivering comprehensive supply chain solutions to CVS Caremark which in turn allows CVS Caremark to ensure the highest level of pharmaceutical care to its customers,” said Paul Julian, executive vice president, group president, McKesson Corporation. “We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.”
July 29, 2014
16:32 EDTESRXExpress Scripts sees FY15 retention rate 92%-93%
Subscribe for More Information
16:30 EDTESRXExpress Scripts reports Q2 adjusted claims 324.5M
Subscribe for More Information
16:30 EDTESRXExpress Scripts sees Q3 adjusted EPS $1.27-$1.31, consensus $1.29
Subscribe for More Information
16:28 EDTESRXExpress Scripts narrows FY14 EPS view to $4.84-$4.92 from $4.82-$4.94
Consensus $4.86.
16:27 EDTESRXExpress Scripts reports Q2 adjusted EPS $1.23, consensus $1.22
Reports Q2 revenue $25.11B, consensus $24.38B.
15:53 EDTESRXNotable companies reporting after market close
Subscribe for More Information
07:55 EDTCVS, ESRX, CTRXLeerink a buyer of Catamaran ahead of Q2 results
Leerink says it's a buyer of Catamaran (CTRX) ahead of the company's Q2 results as it believes shares have more room to run. The firm is cautious on Express Scripts (ESRX) after hearing from a specialist that service challenges may impact the company's 2015 and 2016 selling seasons. The firm remains positive on CVS Caremark (CVS), but notes shares have outperformed and the company could see retail pressure from recent drug inflation trends.
July 28, 2014
12:21 EDTESRX, CVSOn The Fly: Midday Wrap
Subscribe for More Information
10:26 EDTESRXExpress Scripts August weekly volatility elevated into Q2 and outlook
Subscribe for More Information
09:17 EDTCVSOn The Fly: Pre-market Movers
Subscribe for More Information
06:22 EDTCVS, ESRXHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Subscribe for More Information
July 23, 2014
09:30 EDTESRXExpress Scripts downgraded to Neutral from Buy at Cleveland Research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use